FDA Approved: TYVASO — Original Application (United Therapeutics Corporation)

View source ↗

Summary

The FDA approved TYVASO (treprostinil) under its Original Application from United Therapeutics Corporation for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Tyvaso (treprostinil)

Snippet

ORIG AP for TYVASO (TREPROSTINIL)